Cambridge Cognition Holdings Plc (LON:COG – Get Free Report) passed below its 200-day moving average during trading on Wednesday. The stock has a 200-day moving average of GBX 32.88 and traded as low as GBX 27. Cambridge Cognition shares last traded at GBX 27.89, with a volume of 5,089 shares.
Cambridge Cognition Stock Performance
The firm’s fifty day moving average price is GBX 29.15 and its 200 day moving average price is GBX 32.81. The stock has a market capitalization of £14.57 million, a price-to-earnings ratio of -8.71 and a beta of 0.81. The company has a current ratio of 0.41, a quick ratio of 0.96 and a debt-to-equity ratio of 10.91.
Cambridge Cognition (LON:COG – Get Free Report) last issued its quarterly earnings results on Wednesday, September 16th. The company reported GBX (1.60) earnings per share for the quarter. Cambridge Cognition had a negative return on equity of 54.17% and a negative net margin of 13.86%. Analysts forecast that Cambridge Cognition Holdings Plc will post 1.03 EPS for the current fiscal year.
Cambridge Cognition Company Profile
Cambridge Cognition Holdings Plc, a neuroscience technology company, develops and markets near-patient cognitive testing techniques in the United States, United Kingdom, the European Union, and internationally. The company offers CANTAB digital cognitive assessment platform for drug development by enabling pharmaceutical companies to take new therapeutics from preclinical consultancy to pivotal studies and approval, as well as supports sponsors to enhance recruitment, develop safe and effective treatments, and enhance research and development efficiency.
Recommended Stories
- Five stocks we like better than Cambridge Cognition
- Spotify Soars After Earnings as the Company Touts AI Benefits and Moderating Costs
- Lockheed Martin’s Record $292 Billion Backlog Comes With a Delivery Test
- Palantir’s Next Big Test Isn’t a Partnership—It’s the Numbers
- Kinder Morgan’s $4.7 Billion Pipeline Bet Could Be Bigger Than Its Earnings Beat
Receive News & Ratings for Cambridge Cognition Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cambridge Cognition and related companies with MarketBeat.com's FREE daily email newsletter.
